Jezierzański, M.; Nafalska, N.; Stopyra, M.; Furgoł, T.; Miciak, M.; Kabut, J.; Gisterek-Grocholska, I.
Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes. Curr. Oncol. 2024, 31, 3994-4002.
https://doi.org/10.3390/curroncol31070296
AMA Style
Jezierzański M, Nafalska N, Stopyra M, Furgoł T, Miciak M, Kabut J, Gisterek-Grocholska I.
Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes. Current Oncology. 2024; 31(7):3994-4002.
https://doi.org/10.3390/curroncol31070296
Chicago/Turabian Style
Jezierzański, Marcin, Natalia Nafalska, Małgorzata Stopyra, Tomasz Furgoł, Michał Miciak, Jacek Kabut, and Iwona Gisterek-Grocholska.
2024. "Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes" Current Oncology 31, no. 7: 3994-4002.
https://doi.org/10.3390/curroncol31070296
APA Style
Jezierzański, M., Nafalska, N., Stopyra, M., Furgoł, T., Miciak, M., Kabut, J., & Gisterek-Grocholska, I.
(2024). Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes. Current Oncology, 31(7), 3994-4002.
https://doi.org/10.3390/curroncol31070296
